It is well-established that psychological distress reduces natural killer cell activity (NKCA) and dysregulates cytokine balance. This may be mediated by stress-induced release of glucocorticoids, which have broad effects on the immune system, including the suppression of NKCA and alteration of cytokine production. The purpose of this study was to evaluate epigenetic mechanisms that may underlie the effect of glucocorticoids on NK cells, using the human NK cell line, NK92. Treatment of NK92 cells with the synthetic glucocorticoid, dexamethasone, at a concentration of 10 À7 M, produced a significant reduction in NKCA. Glucocorticoid inhibition was a consequence of not only a reduced capacity of the NK cells to bind to tumor targets but also a reduced production of granule constituents (perforin and granzyme B) with no detectable effect on granule exocytosis. Glucocorticoids also reduced the constitutive and the stimulated production of the cytokines, IL-6, TNF alpha and IFN gamma, and reduced the surface expression of LFA-1. Glucocorticoid treatment also reduced global histone acetylation, the acetylation of histone 4 lysine position 8, and the accessibility of the proximal promoters of perforin, interferon gamma and granzyme B. Histone acetylation was recovered by treatment of the NK cells with a histone deacetylase inhibitor, which also restored NKCA and IFN gamma production. These results demonstrate glucocorticoids to dysregulate NK cell function at least in part through an epigenetic mechanism, which reduces promoter accessibility through modification of histone acetylation status. This epigenetic modification decreases the expression of effector proteins necessary to the full functional activity of NK cells.
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Introduction
Natural killer (NK) cells are multi-functional lymphocytes that do not require a pre-activation process and are not restricted to antigen presentation by major histocompatibility complex molecules. Their rapid action places NK cells as a front line of defense against cancer and infectious agents (Biron, 1999; Gumperz and Parham, 1995; Trinchieri, 1989) . Considerable attention has been paid to the direct anti-tumor activities of NK cells (Alexandroff et al., 1998) and evidence has existed for some time for their role in tumor protection. However, more recent direct evidence has shown these cells to be involved in immune surveillance, controlling the initiation and growth of tumors (Dighe et al., 1994; Kagi et al., 1994; Kaplan et al., 1998; Smyth et al., 1998 Smyth et al., , 1999 Street et al., 2001; Van Den Broek et al., 1996; Seki et al., 2003) . NK cells produce their effects against tumor cells by first engaging the tumor target, followed by exocytosis of NK cytolytic granule constituents against the tumor cell, disengagement of the tumor cell by the NK cell and lysis of the tumor targets.
A large number of studies have shown psychological distress to negatively impact immune function (Witek-Janusek and Mathews, 2000; Kemeny and Schedlowski, 2007; Glaser and Kiecolt-Glaser, 2005; Segerstrom and Miller, 2004) . Reciprocal neuro-chemical pathways and shared receptor systems link the brain and the immune system and provide biological pathways whereby one's emotions influence immune function. NK cell activity (NKCA) is especially responsive to the impact of psychological stress and ample evidence demonstrates that psychological distress or negative affective states reduce NKCA (Biondi, 2001; Kiecolt-Glaser et al., 1987) . Psychological distress also results in an altered pattern of cytokine production (Maes et al., 1999; Marshall et al., 1998; Witek-Janusek et al., 2007) , including reductions in the production of interferon (IFN) gamma 0889-1591/$ -see front matter Ó 2010 Elsevier Inc. All rights reserved. doi:10.1016/j.bbi.2010.07.244 q All authors declare that there are no conflicts of interest.
